Merrimack Pharmaceuticals Volatility

MACKDelisted Stock  USD 11.96  0.12  1.01%   
We have found twenty-four technical indicators for Merrimack Pharmaceuticals, which you can use to evaluate the volatility of the firm. Please verify Merrimack Pharmaceuticals' Standard Deviation of 1.12, risk adjusted performance of (0.03), and Mean Deviation of 0.7806 to check out if the risk estimate we provide is consistent with the expected return of 0.0%. Key indicators related to Merrimack Pharmaceuticals' volatility include:
360 Days Market Risk
Chance Of Distress
360 Days Economic Sensitivity
Merrimack Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Merrimack daily returns, and it is calculated using variance and standard deviation. We also use Merrimack's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Merrimack Pharmaceuticals volatility.
  
Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Merrimack Pharmaceuticals at lower prices. For example, an investor can purchase Merrimack stock that has halved in price over a short period. This will lower their average cost per share, thereby improving the overall portfolio performance when market normalizes.

Moving together with Merrimack Stock

  0.79BKRKY Bank RakyatPairCorr
  0.8TLK Telkom Indonesia TbkPairCorr
  0.65PPERF Bank Mandiri PerseroPairCorr
  0.83PPERY Bank Mandiri PerseroPairCorr
  0.77PBCRY Bank Central AsiaPairCorr

Moving against Merrimack Stock

  0.75CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.7WMT Walmart Aggressive PushPairCorr
  0.61AXP American Express Fiscal Year End 24th of January 2025 PairCorr
  0.59CSCO Cisco Systems Aggressive PushPairCorr
  0.54T ATT Inc Fiscal Year End 22nd of January 2025 PairCorr
  0.5AA Alcoa Corp Fiscal Year End 15th of January 2025 PairCorr
  0.43SSNLF Samsung ElectronicsPairCorr
  0.42HPQ HP IncPairCorr
  0.36PTAIF PT Astra InternationalPairCorr

Merrimack Pharmaceuticals Market Sensitivity And Downside Risk

Merrimack Pharmaceuticals' beta coefficient measures the volatility of Merrimack stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Merrimack stock's returns against your selected market. In other words, Merrimack Pharmaceuticals's beta of 0.0765 provides an investor with an approximation of how much risk Merrimack Pharmaceuticals stock can potentially add to one of your existing portfolios. Merrimack Pharmaceuticals exhibits very low volatility with skewness of -0.85 and kurtosis of 4.38. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Merrimack Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Merrimack Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Merrimack Pharmaceuticals Demand Trend
Check current 90 days Merrimack Pharmaceuticals correlation with market (Dow Jones Industrial)

Merrimack Beta

    
  0.0765  
Merrimack standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  0.0  
It is essential to understand the difference between upside risk (as represented by Merrimack Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Merrimack Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in merrimack stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Merrimack Pharmaceuticals.

Merrimack Pharmaceuticals Stock Volatility Analysis

Volatility refers to the frequency at which Merrimack Pharmaceuticals delisted stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Merrimack Pharmaceuticals' price changes. Investors will then calculate the volatility of Merrimack Pharmaceuticals' stock to predict their future moves. A delisted stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile delisted stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Merrimack Pharmaceuticals' volatility:

Historical Volatility

This type of delisted stock volatility measures Merrimack Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Merrimack Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Merrimack Pharmaceuticals' current market price. This means that the delisted stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Merrimack Pharmaceuticals' to be redeemed at a future date.
Transformation
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.

Merrimack Pharmaceuticals Projected Return Density Against Market

Given the investment horizon of 90 days Merrimack Pharmaceuticals has a beta of 0.0765 . This indicates as returns on the market go up, Merrimack Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Merrimack Pharmaceuticals will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Merrimack Pharmaceuticals or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Merrimack Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Merrimack delisted stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Merrimack Pharmaceuticals has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Predicted Return Density   
       Returns  
Merrimack Pharmaceuticals' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how merrimack stock's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a Merrimack Pharmaceuticals Price Volatility?

Several factors can influence a delisted stock's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

Merrimack Pharmaceuticals Stock Return Volatility

Merrimack Pharmaceuticals historical daily return volatility represents how much of Merrimack Pharmaceuticals delisted stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 0.0% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7472% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About Merrimack Pharmaceuticals Volatility

Volatility is a rate at which the price of Merrimack Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Merrimack Pharmaceuticals may increase or decrease. In other words, similar to Merrimack's beta indicator, it measures the risk of Merrimack Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Merrimack Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts. Merrimack Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Merrimack Pharmaceuticals' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Merrimack Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Merrimack Pharmaceuticals' price varies over time.

3 ways to utilize Merrimack Pharmaceuticals' volatility to invest better

Higher Merrimack Pharmaceuticals' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Merrimack Pharmaceuticals stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Merrimack Pharmaceuticals stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Merrimack Pharmaceuticals investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in Merrimack Pharmaceuticals' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of Merrimack Pharmaceuticals' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

Merrimack Pharmaceuticals Investment Opportunity

Dow Jones Industrial has a standard deviation of returns of 0.75 and is 9.223372036854776E16 times more volatile than Merrimack Pharmaceuticals. 0 percent of all equities and portfolios are less risky than Merrimack Pharmaceuticals. You can use Merrimack Pharmaceuticals to enhance the returns of your portfolios. The stock experiences a large bullish trend. Check odds of Merrimack Pharmaceuticals to be traded at $13.16 in 90 days.

Significant diversification

The correlation between Merrimack Pharmaceuticals and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Merrimack Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Merrimack Pharmaceuticals Additional Risk Indicators

The analysis of Merrimack Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Merrimack Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Merrimack Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar delisted stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Merrimack Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Merrimack Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Merrimack Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Merrimack Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Merrimack Pharmaceuticals.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in Merrimack Stock

If you are still planning to invest in Merrimack Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Merrimack Pharmaceuticals' history and understand the potential risks before investing.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stocks Directory
Find actively traded stocks across global markets